A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer
neoadjuvant/adjuvant chemotherapy within 6 months prior to enrollment;
radical radiotherapy with curative intent within 28 days prior to enrollment;
history of \>=grade 2 hemoptysis in 3 months prior to enrollment;
evidence of CNS metastases;
current or recent (within 10 days of first dose of Avastin)use of aspirin (\>325 mg/day)or full dose anticoagulants or thrombolytic agents for therapeutic purposes.
Clareo Health | A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer
